HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Non-traumatic splenic rupture after discontinuation of zanubrutinib and venetoclax therapy in relapsed/refractory diffuse large B-cell lymphoma.

AuthorsYao Qin, Kai Shen, Jiaqi Pu, Ting Liu, Hongbing Ma
JournalAnnals of hematology (Ann Hematol) Vol. 101 Issue 10 Pg. 2379-2380 (10 2022) ISSN: 1432-0584 [Electronic] Germany
PMID35819499 (Publication Type: Letter)
Chemical References
  • Bridged Bicyclo Compounds, Heterocyclic
  • Piperidines
  • Pyrazoles
  • Pyrimidines
  • Sulfonamides
  • zanubrutinib
  • venetoclax
Topics
  • Bridged Bicyclo Compounds, Heterocyclic
  • Humans
  • Lymphoma, Large B-Cell, Diffuse (drug therapy)
  • Lymphoma, Non-Hodgkin (pathology)
  • Piperidines
  • Pyrazoles
  • Pyrimidines
  • Splenic Rupture (etiology)
  • Sulfonamides

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: